AI-ACCELERATED DRUG DISCOVERY

AI-accelerated SaaS Platform for Rapid & Precise Drug Design

Our SaaS platform features an intuitive user interface that streamlines the automation, planning, and oversight of multiple drug discovery workflows running in parallel.

Drug Design Flow

AI-accelerated SaaS Platform for Rapid & Precise Drug Design

Our SaaS platform features an intuitive user interface that streamlines the automation, planning, and oversight of multiple drug discovery workflows running in parallel.

Accelerated

40+ advanced AI methodologies open up a new high-speed avenue for drug candidate design

Precise

Molecules are designed with atom-like precision through a holistic approach

Customizable

Modular platform architecture can be easily fine-tuned to make drug design more flexible

Validated

Our experimentally-proven platform integrates biological assays to deliver high-quality medicines

Seamless drug design workflow

Chemical Space Preprocessing
Novel Chemical Space
Generate virtual chemical space with trillions of synthesizable compounds using structure-based AI methodologies and chemical synthesis simulation techniques.
Novel Chemical Space
Large Chemical Libraries
Large Chemical Libraries
Start with your own compound library or choose from our extensive selection of commercial libraries, each containing billions of compounds with an 80% synthesizability rate.
Optimised Screening Map
Perform clusterization and navigation in large datasets for fast and effective screening of bioactive compounds.
Optimised Chemical Map
Drug-Like Chemical Space
Drug-Like Chemical Space
Filter compounds using an extensive set of 32 physchem and drug-like properties.
Seamless drug design workflow
Chemical Space Preprocessing
Novel Chemical Space
Generate virtual chemical space with trillions of synthesizable compounds using structure-based AI methodologies and chemical synthesis simulation techniques.
Novel Chemical Space
Large Chemical Libraries
Start with your own compound library or choose from our extensive selection of commercial libraries, each containing billions of compounds with an 80% synthesizability rate.
Large Chemical Libraries
Optimised Chemical Map
Perform clusterization and navigation in large datasets for fast and effective screening of bioactive compounds.
Optimised Chemical Map
Drug-Like Chemical Space
Filter compounds using an extensive set of 32 physchem and drug-like properties.
Drug-Like Chemical Space
Massive Virtual Screening
Protein Structure Preparation
Define your protein target and pockets by providing its aminoacid sequence or its available 3D structure.
Protein Structure Preparation
Protein-Ligand Preparation
Perform protein structurepre-processing and optimization.Chemical data augmentation and2D/3D similarity filtering.
Protein-Ligand Preparation
Ligand- and Structure-basedVirtual Screening
AI-enabled virtual screening to pinpoint exceptionally promising bioactive compounds without requiring known ligands as templates. This opens up untapped avenues in the chemical space, allowing for the exploration of diverse and novel molecular structures.
Ligand- and Structure-basedVirtual Screening
Massive Virtual Screening
Protein Structure Preparation
Protein Structure Preparation
Define your protein target and pockets by providing its aminoacid sequence or its available 3D structure.
Protein-Ligand Preparation
Perform protein structure pre-processing and optimization. Chemical data augmentation and2D/3D similarity filtering.
Protein-Ligand Preparation
Ligand- and Structure-basedVirtual Screening
Ligand- and Structure-based Virtual Screening
AI-enabled virtual screening to pinpoint exceptionally promising bioactive compounds without requiring known ligands as templates. This opens up untapped avenues in the chemical space, allowing for the exploration of diverse and novel molecular structures.
Precision Screening
Safety
Innovative safety assessment with multi-task ADME-Tox Prediction System comprising 40+ AI pharmacokinetic endpoints
Safety
Polypharmacology
Perform advanced ligand- and structure-based multi-target profiling and selectivity assessment against ~9K+ human proteins.
Polypharmacology
Efficacy
AI-enabled virtual screening to pinpoint exceptionally promising bioactive compounds without requiring known ligands as templates. This opens up untapped avenues in the chemical space, allowing for the exploration of diverse and novel molecular structures.
Efficacy
Precision Screening
Safety
Innovative safety assessment with multi-task ADME-Tox Prediction System comprising 40+ AI pharmacokinetic endpoints
Safety
Polypharmacology
Polypharmacology
Perform advanced ligand- and structure-based multi-target profiling and selectivity assessment against ~17K+ human proteins.
Efficacy
Reveal top compounds using quantitative structure-activity relationship assessment and physics-based simulations.
Efficacy
Candidate compounds
Safety
Efficacy
Affinity
Selectivity
Stability
Bioavailability
Candidate compounds
Safety
Efficacy
Affinity
Selectivity
Stability
Bioavailability
Scalable Hybrid Cloud Infrastructure
A high-performance cloud infrastructure of our AI platform is designed to efficiently implement large-scale drug discovery projects in a matter of days

Speed

Our cloud infrastructure managing system gives access to unlimited computing resources and enables to run multiple drug discovery workloads in parallel.

Automation

Combining the capacities of the modular architecture of our AI platform, we have automated heterogeneous data storage, collecting and processing.

Scalability

The flexible configuration of our platform offers virtually unrestricted capabilities for scaling up or down the infrastructure for any drug discovery workflow.

Security

Our platform is driven by edge-cutting technologies to strictly observe software security, data networking, and information storage.